Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07291375 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Role of Amlodipine in Reduction of CIN

StatusNot Yet Recruiting
PhaseEarly Phase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 18, 2025 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Minia University
133 trials monitored
See 3 trials at risk
The aim is to assess the benefit of low dose oral amlodipine in renal protection from contrast induced nephropathy in diabetic patients in intensive care unit
Trial Details
NCT Number NCT07291375
Lead Sponsor Minia University
Conditions
(from sponsor)		 Contrast-induced Nephropathy
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov